# To Evaluate The Safety and Efficacy of AVI Stent Comparing With Firebird2® For Treating Coronary Revascularization

Study · id `cardio:ct-nct02133287` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02133287](<https://clinicaltrials.gov/study/NCT02133287>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02133287

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT02133287. Randomized; no masking; primary purpose treatment. Start 2013-08 (actual); primary completion 2018-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT02133287, source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)
- Started: 2013-08 (actual) (ClinicalTrials.gov record NCT02133287, source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)
- Primary completion: 2018-06 (actual) (ClinicalTrials.gov record NCT02133287, source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)
- Completion: 2022-11 (anticipated) (ClinicalTrials.gov record NCT02133287, source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02133287, source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02133287-2019-11-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
- Condition: Ischemic Heart Disease
- Condition: Myocardial Ischemia
- Condition: Coronary Disease
- Condition: Acute Coronary Syndrome
- Intervention (Device): AVI® Arsenic trioxide drug eluting stent delivery system
- Intervention (Device): Firebird2® sirolimus eluting stent system
- Lead sponsor: Beijing AmsinoMed Medical Device Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

## Provenance

Content hash: 03ef12488697becb1459d73ca50a577eae587b685b91539fb2a924930206b3b0
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
